Why Belite Bio, Inc (BLTE) stock rose 9.0% on Thursday, November 12, 2026
Belite Bio, Inc (BLTE) closed at $169.96, up 8.99% on Thursday, November 12, 2026, on volume of 495,459 shares (2.7× its 3-month average); market value about $6.80B, according to Nexqual market data (nexqual.com/moves/2026-11-12/BLTE).
What happened: primary sources
Events Nexqual found for BLTE on Thursday, November 12, 2026 or the trading day before (November 11, 2026), each linked to its primary source:
- Nov 12, 2026: SEC 6-K: Current report (foreign issuer), period ended Nov 12, 2026 source
These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.
More on BLTE
BLTE stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 12, 2026.
Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 18, 2026 at 20:49 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 18, 2026 at 20:49 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt